You are here

weight loss

Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns

CBS News

Thu, 05/15/25 - 10:47 am

Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill

BioSpace

Mon, 05/5/25 - 11:29 am

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool

Sun, 05/4/25 - 12:09 pm

Viking Therapeutics

WHO set to back use of weight-loss drugs for adults globally, raises cost issue

MSN/Reuters

Thu, 05/1/25 - 10:28 pm

Gene therapy loses luster as investors eye quicker returns from weight-loss drugs

Yahoo/Reuters

Fri, 03/21/25 - 11:42 am

drug development

Patients scramble as cheaper obesity drug alternatives disappear

NPR

Thu, 03/20/25 - 11:15 am

compounding pharmacies

Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial

MSN/Reuters

Thu, 03/20/25 - 10:18 am

Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients

Fierce Pharma

Wed, 03/5/25 - 11:59 am

drug compounding

As Money Pours Into Weight Loss Drugs, Physicians Prioritize Efficacy, Access

BioSpace

Thu, 02/27/25 - 11:18 am

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

CNBC

Tue, 02/25/25 - 11:14 am

Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile

US News and World Report

Thu, 02/20/25 - 06:07 pm

clinical trials

3 trial readouts that could shake up the obesity market this year

Pharma Voice

Wed, 01/8/25 - 11:15 am

Skye Bioscience

clinical trials

Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing

Fierce Biotech

Tue, 01/7/25 - 06:57 pm

Novo’s next-gen obesity drug misses expectations in closely watched trial

BioPharma Dive

Fri, 12/20/24 - 11:34 am

clinical trials

A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss

Pharmaphorum

Wed, 12/18/24 - 11:14 am

Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial

BioPharma Dive

Wed, 12/4/24 - 11:02 am

clinical trials

Weight-loss drug coverage rises among largest US employers, Mercer survey finds

MSN/Reuters

Wed, 11/20/24 - 11:30 am

Drugmakers and pharmacists battle over who gets to make obesity drugs

NPR

Wed, 11/20/24 - 11:21 am

compounded drugs

Novo’s Wegovy Launched in China at a Fraction of US Price

BioSpace

Mon, 11/18/24 - 11:28 am

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

Xtalks

Fri, 11/15/24 - 11:27 am

Pages